Jim Simons Biocryst Pharmaceuticals Inc Transaction History

Renaissance Technologies LLC

$70.6 Billion
Q2 2025

A detailed history of Jim Simons (Renaissance Technologies LLC) transactions in Biocryst Pharmaceuticals Inc stock. As of the latest transaction made, Renaissance Technologies LLC holds 2,526,734 shares of BCRX stock, worth $17.5 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares

2,526,734

Previous 605,218 317.49%

Holding current value

$17.5 Million

Previous $4.54 Million 398.77%

% of portfolio

0.03%

Previous 0.01%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 13, 2025	BUY	$6.41 - $11.19 $12.3 Million - $21.5 Million	1,921,516 Added 317.49%	2,526,734 $22.6 Million
Q1 2025 May 14, 2025	BUY	$7.06 - $9.39 $424,990 - $565,249	60,197 Added 11.04%	605,218 $4.54 Million
Q4 2024 Feb 13, 2025	SELL	$7.03 - $8.43 $309,734 - $371,417	-44,059 Reduced 7.48%	545,021 $4.1 Million
Q3 2024 Nov 13, 2024	SELL	$6.41 - $8.69 $2.38 Million - $3.22 Million	-371,100 Reduced 38.65%	589,080 $4.48 Million
Q2 2024 Aug 09, 2024	SELL	$4.13 - $6.79 $2.6 Million - $4.28 Million	-630,200 Reduced 39.63%	960,180 $5.93 Million
Q1 2024 May 13, 2024	SELL	$4.89 - $7.65 $804,894 - $1.26 Million	-164,600 Reduced 9.38%	1,590,380 $8.08 Million
Q4 2023 Feb 13, 2024	BUY	$4.98 - $6.77 $7.73 Million - $10.5 Million	1,553,135 Added 769.47%	1,754,980 $10.5 Million
Q3 2023 Nov 14, 2023	BUY	$6.71 - $7.92 $1.35 Million - $1.6 Million	201,845 New	201,845 $1.43 Million
Q3 2022 Nov 14, 2022	BUY	$10.79 - $14.81 $4.74 Million - $6.5 Million	438,900 Added 347.01%	565,380 $7.12 Million
Q2 2022 Aug 12, 2022	SELL	$7.89 - $17.88 $986,250 - $2.24 Million	-125,000 Reduced 49.71%	126,480 $1.34 Million
Q1 2022 May 13, 2022	BUY	$11.56 - $19.76 $2.91 Million - $4.97 Million	251,480 New	251,480 $4.09 Million
Q4 2021 Feb 11, 2022	SELL	$11.18 - $15.46 $4.56 Million - $6.31 Million	-408,180 Closed	0 $0
Q3 2021 Nov 12, 2021	SELL	$14.21 - $17.65 $8.87 Million - $11 Million	-624,300 Reduced 60.47%	408,180 $5.87 Million
Q2 2021 Aug 13, 2021	BUY	$9.5 - $17.24 $9.17 Million - $16.6 Million	965,010 Added 1430.28%	1,032,480 $16.3 Million
Q1 2021 May 13, 2021	SELL	$7.37 - $13.61 $8.94 Million - $16.5 Million	-1,212,910 Reduced 94.73%	67,470 $686,000
Q4 2020 Feb 10, 2021	BUY	$3.37 - $8.61 $4.31 Million - $11 Million	1,280,380 New	1,280,380 $9.54 Million
Q1 2020 May 14, 2020	SELL	$1.6 - $4.11 $1.35 Million - $3.46 Million	-840,734 Closed	0 $0
Q4 2019 Feb 13, 2020	BUY	$1.59 - $3.45 $1 Million - $2.17 Million	629,919 Added 298.8%	840,734 $2.9 Million
Q3 2019 Nov 13, 2019	BUY	$2.5 - $3.73 $527,037 - $786,339	210,815 New	210,815 $604,000

Others Institutions Holding BCRX

# of Institutions

315

Shares Held

201M

Call Options Held

930K

Put Options Held

553K

View Full List

About BIOCRYST PHARMACEUTICALS INC

Ticker BCRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,944,992
Market Cap $1.29B
Description
BioCryst Pharmaceuticals, Inc., a biotechnology company, discovers novel, oral, and small-molecule medicines. The company markets peramivir injection, an intravenous neuraminidase inhibitor for the treatment of acute uncomplicated influenza under the RAPIVAB, RAPIACTA, and PERAMIFLU names; and ORLADEYO, an oral serine protease inhibitor to treat...

More about BCRX

Track Jim Simons's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.

Account